• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Maxygen Inc


Ticker Delisted

Snapshot for Maxygen Inc (MAXY)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for MAXY

No chart data available.
  • MAXY:US 2.5300
  • 1M
  • 1Y
Interactive MAXY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MAXY

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3600
Est. EPS (USD) (12/2013) -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 27.79
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 2.5000
Dividend Ex-Date 08/30/2013
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MAXY

No data available

Company Profile & Key Executives for MAXY

Maxygen, Inc. is a biopharmaceutical company which researches and develops protein drugs. The Company's products now in clinical trials include an interferon alpha for treating Hepatitis C, and a G-CSF for treating neutropenia.

Isaac SteinChairman/CEO/CFO/Co-FounderJohn M BorkholderSecretary/General Counsel
More Company Profile & Key Executives for MAXY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil